Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 4

Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.

Well- Konnect Healthcare Services and Research Firm · with National Institutes of Health (NIH) · NCT06441955

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–65 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 4
Target enrollment
100
US sites recruiting
1
Study start
March 1, 2024
Record last updated
November 27, 2024

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Investigators are conducting a study on alternative treatments for patients who have received an current or previous positive COVID-19 diagnosis with mild-serve symptoms or undiagnosable condition after testing positive for severe acute COVID-19 infection and are experiencing long-haul symptoms. The symptoms of long COVID can include extreme tiredness (fatigue), shortness of breath, memory and concentration issues (brain fog), heart palpitations, dizziness, joint pain, muscle aches, cough, headaches, anxiety, and depression.

It's important to note that there are various other symptoms that individuals can experience after a COVID-19 infection, such as loss of smell, chest pain or tightness, difficulty sleeping (insomnia), pins and needles, depression, anxiety, tinnitus, earaches, nausea, diarrhea, stomach aches, loss of appetite, cough, headaches, sore throat, and changes to the sense of smell or taste.

To be included in the study, participants must have had symptoms for more than 4 weeks. The goal of the study is to measure biomarkers, identify new ones through clinical trials, and individualize and optimize treatment plans, which may or may not include COVID-19 post-market antivirals, vaccines, and medical care.

It's essential to conduct thorough clinical trials to understand the long-term effects of COVID-19 and to develop personalized treatment plans for individuals experiencing long-haul symptoms.

Being studied: Ritonavir-Boosted Nirmatrelvir (Paxlovid); Physiological Evaluation; Moderna COVID-19 Vaccine; Biopsychological; Behavioral (e.g., Psychotherapy, Lifestyle Counseling); Genetic (including gene transfer, stem cell and recombinant DNA); Multidisciplinary approach

Conditions: COVID-19, Long Haul

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Inclusion of Men, Women, and Minorities
  • Participants must be at least 18 years old.
  • Participants must have a positive COVID-19 diagnosis or clinical diagnosis of COVID-19
  • Participants must have experienced persistent symptoms after recovering from the acute phase of the illness.
  • Participants must be willing to provide informed consent to participate in the study.
  • Participants must be able to communicate effectively in English or have a translator available.
  • Participants must be able to attend follow-up appointments as required by the study protocol.
  • Participants must not have any medical conditions or take any medications that could interfere with the study results.

Exclusion Criteria

  • >18 years of age
  • Medical History of Myocarditis
  • Medical History of Pericarditis
  • Medical History of Severe renal impairment (eGFR \<30 mL/min).

Recruiting US locations

  • NIH Clinical Center

    Bethesda, MD 20892

    Site contact: Kawana Williams, Ph.D. · 240-620-1587 · Kawana.williams@waldenu.edu

Study contacts (from the official record)

  • Kawana J Williams, Ph.D. · 2406201587 · Kawana.williams@waldenu.edu
  • KENNY WILLIAMS · 2676067169 · gant2121@gmail.com
All healthy volunteers studies in Maryland →
Covid-19 Long Haul Preventative and Health Promotion Care Clinical… (NCT06441955) | Bored Studies